-
HyperScript™ RT SuperMix for qPCR: NSCLC Workflow
2026-09-22
Build a reproducible two-step qRT-PCR workflow for challenging NSCLC RNA, including low-input samples and structure-rich transcripts. This guide translates the SPI1/miR-616-5p findings from a recent NSCLC study into practical cDNA synthesis, assay-selection, and troubleshooting decisions.
-
PD0325901: From MEK Biology to Translation
2026-09-22
A thought-leadership guide to using PD0325901 as a mechanistic MEK inhibitor research tool, linking RAS/RAF/MEK/ERK signaling, cell-cycle control, apoptosis, xenograft studies, and emerging questions around TERT regulation.
-
Thioredoxin Control of CHK1 Inhibitor Sensitivity
2026-09-21
The 2024 Nature Communications study identifies thioredoxin 1 as a determinant of checkpoint kinase 1 inhibitor sensitivity in non-small cell lung cancer. Its central mechanistic insight is that thioredoxin-dependent redox recycling of ribonucleotide reductase 1 sustains deoxynucleotide production, while thioredoxin reductase inhibition disrupts this supply and can sensitize tumor cells to CHK1 inhibition.
-
Prednisolone: Workflows for Glucocorticoid Research
2026-09-21
Prednisolone offers a practical, well-defined reference compound for glucocorticoid signaling research, inflammation modulation, and cellular response profiling. This workflow also shows how to use it alongside, but not confuse it with, emerging ERAD-engaging degrader technologies for transmembrane proteins.
-
Axitinib (AG 013736) Assay Workflow Guide
2026-09-20
Build more informative VEGF-pathway experiments with Axitinib (AG 013736), from endothelial survival and phosphorylation assays to tumor-growth studies. This workflow separates growth arrest from cell killing, helping cancer biology research teams avoid misleading single-readout conclusions.
-
Ivermectin: Anti-Parasitic Research Workflows
2026-09-19
Ivermectin is an FDA-approved broad-spectrum anti-parasitic used against defined human parasitic infections and in topical products for lice and rosacea. This article connects its neuromuscular mechanism, product specifications, evidence boundaries, and reproducible handling practices to parasitology drug development.
-
Bardoxolone methyl: Redox Research Workflows
2026-09-19
Bardoxolone methyl, also known as CDDO methyl ester, connects Nrf2 activation with NF-kB pathway control in oxidative stress, inflammation, kidney, leukemia, and lung cancer models. This workflow-focused guide shows how to separate pathway engagement from nonspecific cytotoxicity and how to extend redox assays using thioredoxin–RNR biology.
-
N6-Methyl-dATP for DNA Replication Fidelity
2026-09-18
N6-Methyl-dATP enables controlled tests of how an adenine methylation changes DNA polymerase recognition, incorporation, and downstream DNA interactions. This guide translates the LMO2/LDB1 AML findings into practical nucleotide-assay designs while emphasizing controls, storage, interpretation, and troubleshooting.
-
Cy5 amine (non-sulfonated): Labeling Guide
2026-09-17
Cy5 amine (non-sulfonated) is a primary-amine cyanine reagent for covalent fluorescent labeling when a red-emitting signal is needed. It must be dissolved in DMSO or ethanol before use because it is insoluble in water, and it is intended for research workflows rather than diagnostic or medical applications.
-
Cryptosporidium AdhE: Imidazole Screening Insights
2026-09-17
This study identifies the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a metabolically grounded drug target in Cryptosporidium parvum. Enzyme screening, kinetic analysis, and parasite-cell assays connected low-micromolar inhibition by antifungal imidazoles with measurable in vitro anti-cryptosporidial activity, while also defining important limits for translation beyond the assay system.
-
Palonosetron for Chemotherapy-Induced Nausea and Vomiting
2026-09-17
Ruhlmann and Herrstedt review palonosetron as a long-acting 5-HT3 receptor antagonist and assess whether its distinctive receptor pharmacology translates into better control of chemotherapy-induced nausea and vomiting. The article is especially useful for interpreting acute versus delayed emesis evidence, comparing palonosetron with older antagonists, and designing clinically relevant antiemetic studies.
-
SAR131675: An Assay-First VEGFR-3 Guide
2026-09-16
Explore SAR131675, a selective VEGFR-3 inhibitor, through an assay-first framework spanning kinase engagement, lymphangiogenesis, tumor biology, and hepatic fibrosis. Learn how recent VEGFC–macrophage research changes experimental design and interpretation.
-
Shaped ABC Coil-Bottlebrush Terpolymer Self-Assembly
2026-09-15
This study shows that digitally shaped bottlebrush blocks can strongly alter phase selection in ABC coil-bottlebrush terpolymers. Although the materials displayed robust microphase separation, shaped architectures suppressed double-gyroid formation and did not produce rapid structural refinement, establishing important constraints for designing large-period network materials.
-
Imatinib Hydrochloride: State-Aware Kinase Assays
2026-09-15
Imatinib hydrochloride is a versatile tool for kinase-driven oncology research. This article develops a state-aware assay framework that connects target inhibition, phosphorylation turnover, and conformational biology without overstating evidence from p38α studies.
-
SB 225002 CXCR2 Assay Workflows
2026-09-14
SB 225002 offers a selective way to separate CXCR2-dependent neutrophil trafficking from the CXCR1-centered IL-8 signaling reported in oral cancer cells. This guide provides practical chemotaxis workflows, receptor-resolution controls, EV-conditioned models, and troubleshooting strategies.